Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02513745 · ClinicalTrials.gov registry record · NA

Conventional Surgery vs. Verion/VerifEye

A NA study of Cataract and Astigmatism, sponsored by Carolina Eyecare Physicians.

Completed
Registry status
NA
Development phase
84
Enrollment target
1
Study location

NCT02513745: Completed NA study of Cataract and Astigmatism, sponsored by Carolina Eyecare Physicians.

NCT02513745 is a NA study of Cataract and Astigmatism that has completed, run by Carolina Eyecare Physicians. The registered enrollment target is 84 participants, below the 227-participant average among 83 other Cataract trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02513745, a NA study of Cataract and Astigmatism, has completed, sponsored by Carolina Eyecare Physicians.

COMPLETED
Registry status
NA
Development phase
84 participants
Enrollment target
1
Study location

Study Summary

Nowadays cataract patient's expectations are closer to those of refractive surgery patients. Patients want to be spectacle independent. However, fifteen to twenty percent of cataract surgery patients have from 1.00 to 3.00 diopters (D) of corneal astigmatism which makes achieving spectacle independence unlikely in this patients unless the astigmatism is treated at the time of cataract surgery. Option to treat this astigmatism include corneal or limbal incisions (LRIs), the use of toric intraocular lenses (IOLs) or LASIK. Regardless of the treatment of choice to correct the astigmatism at time of cataract extraction, a treatment plan has to be calculated preoperatively. This planning include: keratometry measurements and the use of a calculator to estimate the treatment and orientation of IOL and/or placement of the LRIs. New technology has been developed and is widely used. Among this technology, we have the VERION Image Guided System. This system encompasses a reference unit that takes a picture of the eye with the patient in the sitting position creating image of the patient's eye, capturing scleral vessels, limbus and iris features. It measures keratometry as well as the corneal diameter (limbus) and pupil size. The information captured is transferred automatically to its planner where IOL power calculation and astigmatism correction calculation are completed. Additionally, intraoperative wavefront aberrometry has been used in the last couple of years with increase success.

Primary Outcome

This is the manifest refractive cylinder measured 3 months after surgery. Note that because cataract surgery has been performed, there is no associated baseline value.

Conditions Studied

Interventions

  • DEVICE Conventional
  • DEVICE Refractive Cataract Suite (Verion + ORA)

Study Locations (1)

South Carolina

  • Carolina Eyecare Physicians, LLC - Mt. Pleasant

Trial Details

FieldValue
Enrollment Target 84 participants
Start Date 2015-06
Est. Completion 2017-05-05
Phase NA
Carolina Eyecare Physicians

11 total trials

What the finished NCT02513745 record still lists

NCT02513745 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 84 participants, a relatively small participant target, below the 227-participant average among 83 other Cataract trials with a reported enrollment target (63% lower).

The record links to 2 conditions, with Cataract appearing as the primary indexed condition, and to 2 interventions - of which Conventional is the first listed.

NCT02513745 reports a single indexed study location in South Carolina.

Frequently Asked Questions

What is clinical trial NCT02513745 about?

NCT02513745 is a clinical study titled "Conventional Surgery vs. Verion/VerifEye". Nowadays cataract patient's expectations are closer to those of refractive surgery patients. Patients want to be spectacle independent. However, fifteen to twenty percent of cataract surgery patients have from 1.00 to 3.00 diopters (D) of corneal astigmatism which makes achieving spectacle independe...

What is the current status of trial NCT02513745?

This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2015-06. Estimated completion is 2017-05-05.

What conditions does trial NCT02513745 study?

This clinical trial studies the following conditions: Cataract, Astigmatism.

What interventions are being tested in trial NCT02513745?

The interventions under investigation include: Conventional (DEVICE), Refractive Cataract Suite (Verion + ORA) (DEVICE).

Who is sponsoring clinical trial NCT02513745?

This trial is sponsored by Carolina Eyecare Physicians, which has 11 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02513745 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cataract

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02513745's enrollment target sits among peer trials

84 44th of 83 higher than 40 of 83 other Cataract trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cataract trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02391519 · 84 participants

    Effects of High Altitude on AMPK Activation

  • NCT03838536 · 84 participants · NA

    Synergistic Activity of Human Milk Nutrients and Infant Cognition

  • NCT03884075 · 84 participants · Phase 2

    Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)

  • NCT03894917 · 84 participants

    Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02513745, the US trial registry maintained by the National Library of Medicine. NCT02513745 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.